GlassScriptPhysician profile
Ashish Tiwari
NPI 1104119171
$3,648.96
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,349 · 2020: $910 · 2021: $1,181 · 2022: $209.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,130.16 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $689.80 | 2019-2022 | |
| Gilead Sciences, INC. | $420.63 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $288.46 | 2019-2021 | |
| Janssen Biotech, INC. | $278.30 | 2019-2021 | |
| Pfizer INC. | $137.91 | 2019-2020 | |
| Daiichi Sankyo INC. | $92.36 | 2019-2021 | |
| Ironwood Pharmaceuticals, INC | $75.80 | 2019-2022 | |
| Intercept Pharmaceuticals, INC. | $74.62 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $66.79 | 2019-2020 | |
| Celgene Corporation | $59.86 | 2021-2022 | |
| Ucb, INC. | $55.72 | 2019 | |
| Amag Pharmaceuticals, INC. | $45.65 | 2019 | |
| Allergan, INC. | $44.44 | 2019 | |
| Qol Medical, LLC | $44.29 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dutch Ophthalmic, USA | $38.14 | 2021 | |
| Ferring Pharmaceuticals INC. | $35.27 | 2020 | |
| Alfasigma USA, INC. | $34.36 | 2021 | |
| Redhill Biopharma INC. | $13.07 | 2021 | |
| Medtronic, INC. | $12.13 | 2022 | |
| Dynavax Technologies Corporation | $11.20 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashish Tiwari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.